1 Definition and hazards of insoluble particles

1. definition:Unintentionally present mobile insoluble foreign objects (excluding bubbles) in injections must be strictly detected and controlled.

2. Health risks:After entering the human body, particles cannot be metabolized, which may lead to clinical risks such as vascular blockage, inflammatory reactions, or organ damage, especially for patients with cardiovascular disease, which poses significant harm.

IIRegulatory requirements for upgrading drive technological innovation

1. International standards are becoming increasingly stringent

United States Pharmacopeia (USP): Establish a particle classification system and database through<788><1787>, requiring both quantitative and qualitative analysis;

Chinese Pharmacopoeia 2025 Edition (CP9016):Clearly distinguishExogenous particles(Environmental pollutants, shedding of packaging materials) andEndogenous particles(Raw material crystallization, protein aggregates), requiring full lifecycle control of the drug.

2. Regulatory focus

The tightening of sub micron particle limits for high-risk products such as biologics and implantable devices is driving the popularization of high-precision detection technology.

III Technological breakthrough of AI+microscopic counting method

The YH-MIP-0205pro Microscopic Counting Insoluble Particle Analyzer developed by Yinhuang Technology integrates AI classification technology and microscopic counting principles to meet the needs of pharmaceutical companies' research and development, quality inspection, and particle control throughout the entire lifecycle.

1. Accurate detection capability

Intelligent recognition classification:

Based on the Convolutional Neural Network (CNN) algorithm, real-time differentiation of particle morphology (roundness, aspect ratio) and material (metal/fiber/rubber plug/glass) is achieved with an accuracy rate of over 98%;

Support particle detection at the 0.5 μ m level, breaking through the 2 μ m lower limit limit of traditional photoresist methods

Applicability of complex samples:

Resolve the misjudgment problem of high viscosity, bubble prone, colored, and silicone oil containing samples using photoresist method, and reduce false positivesSexual rate.

Full process automation and data integration

Operational innovation: Fully automated filtering, scanning, counting, and report generation, with single sample detection time reduced to 5 minutes.

Quality warning system: trend analysis of multiple batches of data related to process parameters (such as filling speed, sterilization temperature), identifying particle contamination risk points in advance (such as equipment wear);

Compliant with FDA 21 CFR Part 11 requirements, supporting audit tracking and electronic data traceability.

4 Application Value and Industry Transformation

1. Improvement of quality control efficiency

Injection field:Accurately detect high viscosity and easily dialyzable crystal preparations (such as suspensions and adjuvant vaccines) to avoid batch errors caused by misjudgment of silicone oil dropletsScrap;

medical apparatus and instruments:Identify submicron level metal debris (such as titanium alloy) in the eluent of implanted devices to assist in locating pollution sources (such as injection mold wear),enhanceyield rate.

2. Transformation of Quality Management Paradigm

From passive monitoring to active prevention:

Traceability of particulate components (such as metal shavings → filling line failures) drives process optimization and improves product quality;

Build a data-driven risk warning model to intervene in potential quality issues in advance.

5 Future Development Trends

1. Deepening technology integration

Multimodal integration: integration pullIn situ identification of particle chemical composition using Raman spectroscopy or SEM-EDS (such as differentiation)PLGA degradation products and metal pollutants

Online monitoring integration: Microfluidic chips embedded in the production line, real-time monitoring of particle generation in the filling process, combined with blockchain to achieve data on chain verification.

3. Scenario application expansion

Biological products and cell therapy:
Distinguish between active cells and fragments in cell therapy products (CAR-T) to avoid loss of therapeutic efficacy；

Accurate monitoring of particle size and aggregation state of nanomaterials (such as LNP mRNA vaccines).

summary

The AI+microscopic counting method reconstructs the technical logic of particle detection in the pharmaceutical industry through precise algorithm classification, full process data chain, and adaptability to complex systems. The deep coupling with the upgrading of pharmacopoeia regulations is driving the shift of quality management from "post inspection" to "full cycle prevention and control", providing core guarantees for the safety of high-risk preparations and injecting intelligent driving force into regulatory science.